Although the exact pathophysiology is still unknown, a number of small-scale studies have reported elevated circulating or cerebrospinal fluid (CSF) S100β levels in individuals with nervous system injury, neuroinflammatory conditions, white matter ageing and Alzheimer’s dementia and delirium4–9. This evidence concerns the gene S100B and Alzheimer disease.